Evidence map›Paper›PMID 36467686›Full record

ArticleFrontiers in physiology2022

The metabolomic differential plasma profile between dialysates. Pursuing to understand the mechanisms of citrate dialysate clinical benefits.

José Jesús Broseta, Marta Roca, Diana Rodríguez-Espinosa, Luis Carlos López-Romero, Aina Gómez-Bori, Elena Cuadrado-Payán, Sergio Bea-Granell, Ramón Devesa-Such, Amparo Soldevila, Pilar Sánchez-Pérez and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

José Jesús BrosetaDepartment of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Marta RocaAnalytcal Unit Platform, Medical Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
Diana Rodríguez-EspinosaDepartment of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Luis Carlos López-RomeroDepartment of Nephrology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
Aina Gómez-BoriDepartment of Nephrology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
Elena Cuadrado-PayánDepartment of Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, Barcelona, Spain.
Sergio Bea-GranellDepartment of Nephrology, Consorci Hospital General Universitari de València, Valencia, Spain.
Ramón Devesa-SuchDepartment of Nephrology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
Amparo SoldevilaDepartment of Nephrology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
Pilar Sánchez-PérezDepartment of Nephrology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
Julio Hernández-JarasDepartment of Nephrology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
Hospital Universitari i Politècnic La Fe · ESHospital Clínic de Barcelona · ESHospital General Universitario De Valencia · ESInstituto de Investigación Sanitaria La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acetateacetate-freecitratedialysatehemodialysisuntargeted metabolomics

Identifiers

PMID36467686
PMCPMC9709283
OpenAlexW4309307970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.